2026 Q2 Portfolio Activity
In 2026 Q2, Davern Capital Partners, LP maintained a portfolio of 20 distinct positions. The most significant new addition was ALNYLAM PHARMACEUTICALS INC, now representing 5.80% of the total fund value. They heavily accumulated shares in ROIVANT SCIENCES LTD, increasing the position by 121.3%. Conversely, Davern Capital Partners, LP completely exited their position in PFIZER INC.
Position History
hover any row below to update
Loading…
Total Positions
20
Quarter
2026 Q2
Top Holding
BNTX (12.0%)
Top 10 Concentration
86.8%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-20 of 20
Davern Capital Partners, LP Full Holdings List — 2026 Q2
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
BNTX
BIONTECH SE
|
Healthcare | 11.97% | 7.44% |
#1
5
Prev: #6
|
9.0 |
—
|
449,495 | 147.3% |
P
S
|
754,550 | $70,210,878 |
$94.02
-1.4%
|
2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | ||
|
ROIV
ROIVANT SCIENCE...
|
Healthcare | 11.66% | 6.64% |
#2
8
Prev: #10
|
8.5 |
—
|
1,059,506 | 121.3% |
P
S
|
1,932,904 | $68,405,473 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
RPRX
ROYALTY PHARMA ...
|
Healthcare | 11.05% | 6.84% |
#3
6
Prev: #9
|
8.0 |
—
|
635,800 | 122.3% |
P
S
|
1,155,809 | $64,806,211 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
IONS
IONIS PHARMACEU...
|
Healthcare | 10.80% | 7.97% |
#4
Prev: #4
|
7.5 |
—
|
411,806 | 106.4% |
P
S
|
798,709 | $63,329,637 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
INSM
INSMED INC
|
Healthcare | 10.18% | 8.19% |
#5
2
Prev: #3
|
7.5 |
—
|
377,262 | 206.6% |
P
S
|
559,824 | $59,688,435 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
REGN
REGENERON PHARM...
|
Healthcare | 9.85% | 9.50% |
#6
4
Prev: #2
|
6.9 |
—
|
47,840 | 106.8% |
P
S
|
92,640 | $57,764,746 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
LEGN
LEGEND BIOTECH ...
|
Healthcare | 5.87% | 6.52% |
#7
4
Prev: #11
|
2.8 |
—
|
-123,226 | -9.4% |
P
S
|
1,191,522 | $34,411,155 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
ALNY
ALNYLAM PHARMAC...
|
Healthcare | 5.80% | — |
#8
Prev: #—
|
5.8 |
—
|
113,085 | — |
NEW
|
113,085 | $34,041,978 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
NTRA
NATERA INC
|
Healthcare | 5.51% | 7.90% |
#9
4
Prev: #5
|
2.7 |
—
|
-24,991 | -17.4% |
P
S
|
118,975 | $32,295,764 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
GPCR
STRUCTURE THERA...
|
Healthcare | 4.08% | 1.67% |
#10
6
Prev: #16
|
4.6 |
—
|
319,598 | 252.7% |
P
S
|
446,059 | $23,939,987 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
MLYS
MINERALYS THERA...
|
Healthcare | 3.95% | 3.32% |
#11
1
Prev: #12
|
4.6 |
—
|
411,600 | 92.0% |
P
S
|
858,753 | $23,169,156 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
VERA
VERA THERAPEUTI...
|
Healthcare | 3.65% | — |
#12
Prev: #—
|
5.0 |
—
|
498,832 | — |
NEW
|
498,832 | $21,404,881 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
N/A
GENERATE BIOMED...
|
|
Unknown | 2.37% | 2.03% |
#13
1
Prev: #14
|
3.4 |
—
|
232,879 | 39.4% |
P
S
|
824,679 | $13,912,335 | — | 13F Filing | 2026-06-30 | 2026-08-13 | ||
|
PRCT
PROCEPT BIOROBO...
|
Healthcare | 1.79% | 1.79% |
#14
1
Prev: #15
|
3.7 |
—
|
203,720 | 78.0% |
P
S
|
464,920 | $10,497,894 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
AVTX
AVALO THERAPEUT...
|
Healthcare | 1.48% | — |
#15
Prev: #—
|
4.1 |
—
|
468,666 | — |
NEW
|
468,666 | $8,660,948 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
VRDN
VIRIDIAN THERAP...
|
Healthcare | 0.00% | 1.62% |
Sold All 😨
(Was: #17) |
0.0 |
—
|
-302,457 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
ABVX
ABIVAX SA
|
Healthcare | 0.00% | 2.39% |
Sold All 😨
(Was: #13) |
0.0 |
—
|
-78,125 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
LLY
ELI LILLY & CO
|
Healthcare | 0.00% | 6.88% |
Sold All 😨
(Was: #8) |
0.0 |
—
|
-27,279 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
ARGX
ARGENX SE
|
Healthcare | 0.00% | 7.02% |
Sold All 😨
(Was: #7) |
0.0 |
—
|
-35,045 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
PFE
PFIZER INC
|
Healthcare | 0.00% | 12.28% |
Sold All 😨
(Was: #1) |
0.0 |
—
|
-1,593,942 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 |
Showing 1-20 of 20 holdings